EMAD ATTALLAH-WASIF: Open Payments
NPI 1851581185 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 16 payments from 8 companies in 2025. Trend: 2023 $444 · 2024 $1,840 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $564 |
| ABBVIE INC. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: INCEPTIV, INTELLIS ADAPTIVESTIM, RELISTOR, Belbuca, HORIZANT, UBRELVY, QULIPTA, JOURNAVX.
Industry payments across OK — which companies pay providers there.
